5 Revealing Analyst Questions From UiPath’s Q1 Earnings Call

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

PATH Cover Image

UiPath’s first quarter results saw mixed investor sentiment despite outpacing Wall Street’s revenue expectations, with management highlighting a strong push in enterprise automation and growing adoption of its AI-powered platforms. CEO Daniel Dines cited “continued momentum with our AI products,” emphasizing that 16 of the company’s top 20 deals included AI components and that these expansions were significantly larger than non-AI deals. Management also pointed to improved operational efficiency and the company’s first-ever GAAP profitable quarter, attributing these achievements to disciplined cost management and deeper customer engagement across verticals like healthcare and financial services.

Is now the time to buy PATH? Find out in our full research report (it’s free for active Edge members).

UiPath (PATH) Q1 CY2026 Highlights:

  • Revenue: $418.4 million vs analyst estimates of $397.6 million (17.3% year-on-year growth, 5.2% beat)
  • Adjusted EPS: $0.15 vs analyst estimates of $0.16 (in line)
  • Adjusted Operating Income: $92.49 million vs analyst estimates of $79.93 million (22.1% margin, 15.7% beat)
  • The company lifted its revenue guidance for the full year to $1.78 billion at the midpoint from $1.76 billion, a 1.3% increase
  • Operating Margin: 6.7%, up from -4.6% in the same quarter last year
  • Annual Recurring Revenue: $1.90 billion vs analyst estimates of $1.90 billion (12.3% year-on-year growth, in line)
  • Billings: $369.3 million at quarter end, up 14.2% year on year
  • Market Capitalization: $6.07 billion

While we enjoy listening to the management’s commentary, our favorite part of earnings calls is the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.

Our Top 5 Analyst Questions From UiPath’s Q1 Earnings Call

  • Brian Bergen (TD Cowen) asked about changes in demand trends and pipeline conversion. CFO Ashim Gupta replied that the environment is “relatively stable” and that deal conversion rates are improving, describing the current situation as a “new normal.”

  • Scott Berg (Needham) inquired about the significance of AI modules in top deals. Gupta confirmed that AI components are now a “material” part of major transactions, especially among large enterprise customers, but noted continued demand for traditional automation in mid-tier accounts.

  • Sanjit Singh (Morgan Stanley) questioned the sustainability of license-driven revenue growth versus ARR. Gupta emphasized the high quality of recent deals and explained that differences arise from the timing of license revenue recognition under ASC 606 accounting.

  • Matthew Hedberg (RBC) asked about competitive shifts and the impact of new AI technologies. CEO Daniel Dines highlighted UiPath’s unique platform, which combines deterministic automation with AI, and stated that coding agents are enabling faster automation across a wider range of use cases.

  • Raimo Lenschow (Barclays) sought clarity on the alignment between revenue and ARR growth. Gupta responded that, over a trailing 12-month basis, the metrics are closely aligned, and short-term discrepancies are due to accounting treatment and deal mix.

Catalysts in Upcoming Quarters

In the coming quarters, the StockStory team will be watching (1) further adoption of agentic automation and coding agents among enterprise customers, (2) the pace at which new vertical solutions drive expansion in regulated industries like healthcare and financial services, and (3) UiPath’s ability to deepen integrations with strategic partners such as Deloitte and Microsoft. The trajectory of subscription growth and the impact of macroeconomic headwinds will also be important to track.

UiPath currently trades at $11.29, down from $11.58 just before the earnings. Is the company at an inflection point that warrants a buy or sell? Find out in our full research report (it’s free).

The Best Stocks for High-Quality Investors

ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.

Find out which 5 stocks it’s flagging this month — FREE. Get Our Top 5 Growth Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  246.96
-6.83 (-2.69%)
AAPL  308.20
-3.03 (-0.97%)
AMD  470.37
-52.83 (-10.10%)
BAC  53.73
-0.16 (-0.30%)
GOOG  361.77
-7.50 (-2.03%)
META  590.17
-37.40 (-5.96%)
MSFT  416.44
-11.61 (-2.71%)
NVDA  205.79
-12.87 (-5.88%)
ORCL  212.73
-23.61 (-9.99%)
TSLA  390.73
-27.72 (-6.62%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.